- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
IBB
IBB’s $100 Support Level Goes Back to 2017
This morning I am recommending a bullish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB). I like the biotech sector, and it has generally been holding up well during the recent volatility.
Gilead Sciences Stock Is Back to Base — Go Long
Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.
Go Long Pfizer Stock — It’s an Easy Pill to Swallow
PFE is a proven survivor stock and it now sits on a potential long term technical breakout. Go long its potential with confidence.
Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle
Large-cap biotech stocks as a group rallied along with the broader stock market on Wednesday. While so doing, some big names like AMGN stock broke past key near-term technical resistance.
Biotech ETFs Are the Best Way to Play the Recovering Sector
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks
Both biotech stocks and big pharma stocks involve a different mindset. Treat biotech stocks like options and big pharma stocks like ETFs.
5 Top Stock Trades for Monday Morning
The markets had a big week and bulls are looking to press their luck and fatten their wallets. Here are our top stock trades for Monday.
5 Top Stock Trades for Friday Morning
We saw another strong rally on Thursday in the broader U.S. stock market. That's got us eyeing a few new top stock trades for Friday.
Teva Pharmaceutical Industries Ltd (ADR) Stock Is About to Spike
TEVA stock has potential that is purely technical. Teva Pharmaceutical is showing a breakout that would send it 25% higher from here, so now is the time to go long.
5 Biotech and Pharmaceutical Stocks Going Bonkers
These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy.
Trade of the Day: Celgene Corporation Is a Catch-Up Play
CELG stock continues to notably lag some of its peers in the biotechnology group, but this could soon change and set up a juicy Celgene trade.
Why Now Is the Perfect Time to Short Juno Therapeutics Inc Stock
A 50% pop on speculation is as good a reason to short JUNO stock as any. This is how you should play Juno Therapeutics now.
Trade of the Day: iShares NASDAQ Biotechnology Index (ETF) (IBB)
We will start to see whether investor optimism has been converted into sales this earnings season, which will get into full swing in the next few weeks. In the meantime, I'm looking to trade one of my favorite bullish themes: biotech.
Bet on Biogen Inc for Easy Profits Into the New Year
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
Trade of the Day: Celgene Corporation Attempts a Breakout
CELG stock for the first time in a couple of months is showing a more promising near-term buy signal. Celgene's reward to risk is promising.